Browsing Tag
remdesivir
14 posts
CDC tracks BA.3.2 Cicada COVID variant across 25 US states as WHO flags immune escape risk
CDC tracks BA.3.2 Cicada COVID variant across 25 US states and 23 countries. The heavily mutated SARS-CoV-2 strain raises immune escape and vaccine efficacy concerns.
FDA approves Gilead’s Veklury for COVID-19 patients with severe renal impairment
Gilead Sciences said that the US Food and Drug Administration (FDA) has approved a supplemental new drug application…
Gilead Sciences gets Veklury FDA approval for non-hospitalized Covid-19 patients
Gilead Sciences has secured expedited approval from the US Food and Drug Administration (FDA) for its nucleotide analog…
Natco Pharma signs licensing deal with Lilly for Covid drug Baricitinib
Natco Pharma has signed a royalty-free, non-exclusive, voluntary licensing agreement with Eli Lilly and Company (Lilly) for manufacturing…
Torrent Pharma signs licensing deal with Lilly for Covid drug baricitinib
Torrent Pharmaceuticals (Torrent Pharma) has signed a licensing agreement with Eli Lilly and Company with an objective to…
Dr. Reddy’s Laboratories, Lilly sign deal for Covid-19 drug baricitinib
Dr. Reddy’s Laboratories said that it has forged a royalty-free, non-exclusive voluntary licensing agreement with US pharma giant…
Sun Pharma signs licensing deal with Lilly for Covid-19 drug baricitinib
Sun Pharmaceutical Industries (Sun Pharma) said that it has signed a royalty-free, non-exclusive voluntary licensing agreement with Eli…
Lupin strikes deal with Lilly for Covid-19 drug Baricitinib in India
Lupin Limited said that it has signed a royalty-free, limited, non-exclusive voluntary licensing agreement with Eli Lilly and…
Natco Pharma gets CDSCO nod for use of Baricitinib in Covid patients
Natco Pharma has secured emergency use approval for Baricitinib from India’s Central Drugs Standard Control Organization (CDSCO) for…
Grifols phase 3 Covid-19 trial of hyperimmune globulins fails to meet objective
Spanish pharma company Grifols said that the phase 3 ITAC clinical trial assessing hyperimmune globulins as a treatment…